The three studies suggested that the incidence of driver gene mutations in NSCLC patient is high, and lung cancer driver genes, such as EGFR, ALK, and RET are risk factors for brain metastasis in advanced NSCLC patients. The gene discussed is ALK; the disease is lung carcinoma.